Badreddin Edris, Chief Operating Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 39,600 shares at $55.12 ($2.1M) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Scheduled sale ($2.1M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.12 | 3,924 | $208K | 9.7% |
| 2 | $53.12 | 3,924 | $208K | 9.7% |
| 3 | $54.26 | 12,078 | $655K | 30.5% |
| 4 | $54.26 | 12,078 | $655K | 30.5% |
| 5 | $55.12 | 3,598 | $198K | 9.2% |
| 6 | $55.12 | 3,598 |
| $198K |
| 9.2% |
| 7 | $56.20 | 400 | $22K | 1.0% |
| Total | $54.21 avg | 39,600 | $2.1M | 100% |
| Filing → |
| SWTX | SELL | 2024-12-05 | $1.7M | — | Filing → |
| SWTX | SELL | 2024-09-04 | $1.1M | — | Filing → |
| SWTX | SELL | 2024-06-05 | $1.6M | — | Filing → |